Sunday, January 24, 2010

Tissue Economies: What Can I Get for Two Liters of Blood?











A medevac crew cares for an injured soldier in Jalalabad, Afghanistan

Patrick Barth / Corbis



Biocapital haiku

Micro tissue trade

New technology subject

Subjectivity


What does it mean to give blood? In the Introduction to Tissue Economies Blood, Organs, and Cell Lines in Late Capitalism by Catherine Waldby and Robert Mitchell, they analyze the commodities and gift giving of the human tissue. Waldby and Mitchell start their analysis with the history of blood donations. Starting with the September 11th attacks on the United States, people started to donate blood at a rate where it was difficult for hospitals to keep the units of blood. (Waldby and Mitchell 2006: 2) “It points, we argue to the complex imbrication of giving blood with ideas and feelings about nation, citizenship and community and concepts.” (Waldby and Mitchell 2006: 2) Waldby and Mitchell also mention that during the Second World War people donated their blood as an effort to support the troops.



In current news, the violence has toppled over to Afghanistan from Iraq and the troops need blood. According to a Times news article: Also Moving from Iraq to Afghanistan: Blood Platelets by Mark Thomson the U.S. military uses platelets during procedures that loses large amounts of blood. Air Force Lieutenant Colonel Thomas Jordan stated "We noticed an increase in the survival rate compared to when we were using whole blood." According to the American Red Cross Website, whole blood has a shelf-life up to 42 days which isn’t bad when considering platelets only have a shelf-life of five days. Where do they conjure the elusive elixir? Soldiers in theater are reliant on their comrades to donate blood or specifically platelets to have increasing chances of survival. This creates a sense of investing, for the survival of your company and yourself. What Waldby and Mitchell have observed from Frow, “The gift continues to form a part of the giver even when alienated to another…this link is a kind of property right which persists as an obligation to return the gift, even when the gift passes through a number of hands. We are concerned here with a transaction that perhaps bears rather more resemblance to a loan than to an absolute gift or the alienation of a property right” (Frow 1997: 110)
Titmus would argue that blood is different and that there is no attachment, it’s voluntary so there’s no pressure to reciprocate the gift giving. “It is given not because the giver expects a return, but as an act of voluntary altruism and social duty.” (Waldby and Mitchell 2006: 15) What if the blood doesn’t come from another human being? Wouldn’t it then be a transaction? Scientists have been trying to procure an alternative artificial blood. According to web article on Howstuffworks.com a Discovery company, scientists in the past tried and failed to manufacture artificial blood due to deaths of human trials, but persisted with further research and assuming advanced technology they have narrowed to two substituting classes of blood: Perflourocarbons(PFCs) and Hemoglobin-Based Oxygen Carriers(HBOCs). From the article,

Some of these substitutes are nearing the end of their testing phase and may be available to hospitals soon. Others are already in use. For example, an HBOC called Hemopure is currently used in hospitals in South Africa, where the spread of HIV has threatened the blood supply. A PFC-based oxygen carrier called Oxygent is in the late stages of human trials in Europe and North America. (Wilson 2006)

Other advantages of artificial blood are that they aren’t blood type specific, longer shelf-life and they don’t carry the risk of transmuting diseases. Controversy with artificial blood is that it’s hard to prove that they work, more often are the patients dying than surviving and there are already people with artificial blood that hasn’t actually volunteered to test the serum. These people who have donated their body to science were trauma patients that are usually nonresponsive so the FDA concluded that these patients would be no-consent study. Northfield Laboratories had attempted to educate the communities of study and offered bracelets to indicate that they don’t want to be part of the study, but Northfield Laboratories should do more to advance knowledge of tests and have consent in a more ethical manner. (Wilson 2006)

Works cited

Wilson, Tracy V. "How Artificial Blood Works." 29 December 2006. HowStuffWorks.com. 24 January 2010.

Waldby, Catherine, and Robert Mitchell. 2006. Tissue Economies Blood, Organs, and Cell Lines In Late Capitalism. Durham and London: Duke University Press.

Frow, J. 1997. Time and Commodity Culture: Essays in Cultural Theory and Postmodernity. Oxford: Clarendon.

Images cited

http://health.howstuffworks.com/artificial-blood2.htm


http://www.time.com/time/nation/article/0,8599,1933345,00.html

Saturday, January 16, 2010

Capitalizing on life: What is biocapital?




Biocapitalism can be described literally as capitalism of the living, or materials that are biological. What really intrigues many scholars is the way that biocapitalism is defined and the aspects to the definition. The term is broken down to two definite words, bio and capital. In class we had discussed that the term bio affiliates with the living and life itself where capital is referenced as value, profit and materiality. In Stefan Helmreich article "Species of Biocapital" he references Pierre Bourdieu in the theory of the four species of captial: Economics, Cultural, Social, and symbolic. (p.463) Between the four species they interact and intertwine in creating a dependency to create the whole, capitalism.


Helmreich's article inquires, "What is biocapital? Scholarship in the social and cultural study of biology has suggested that in the age of biotechnology, when the substances and promises of biological materials, particularly stem cells and genomes, are increasingly inserted into projects of product-making and profit-seeking, we are witnessing the rise of a novel kind of capital: biocapital." (pp.463-464) The foundation of creating embryos in the lab and the concept of genes have inspired many experts to explore the possibilities of future analysis. Cultivating life and the theory of creating new and better things have created the commodity of science fiction. The 'hope and hype' that Helmreich references Sunder Rajan (465) has been created to raise investment capital. "Value in the market sense and value in the ethical sense co-constitute one another in biocapital."(465) Helmreich has also referenced Marx, Edward Yoxen, and Foucoult about capitalizing life. 'Life as a productive force: capitalizing upon research in molecular biology' (464) Every discovery and new technology has planted a seed into the minds of the investors creating an imagination for new technology creating faith to researchers and their visions of what may become in the future.


The economics of supply and demand requires the mass population to desire the supply in order for the product to be in demand. In the case of biocapital, Helmreich refers to molecular demand of stem cells and the genomes that the experts apply to their research. The 'supply' that scientists conjure may be of the "speculative enterprise" (465) The major comparisons to Sunder Rajan and Nikolas Rose is the takes on the bio and capital sides of things. Rajan delving more on the capital, "Sunder Rajan takes on board the notion that in the days of genomics, 'biology increasingly becomes an information sciences', a framing that leads him to ask 'where value resides as biology becomes an information science' ". (465)


Nikolas Rose approaches to the more bio side of biocapital. Helmriech interprets Rose's thesis as "Strongly inflected by Foucault as well as Foucault interpreter Paul Rabinow, Rose's thesis is that contemporary biopolitics operates at the level of the molecular and from that seat organizes new landscapes of risk and genres of ethical subjectification." (466) Subjectivity as we discussed in class, incorporates the different subject positions that we are entitled. It is how we identify ourselves and thus creates a formula on how we are supposed to act. Biocapital gives new discoveries and new subjectivities for experts to identify people and for us to identify ourselves.


In last weeks article World as Laboratory: Experiments with Mice, Mazes, and Men. by Rebecca Lemov she goes into what makes us human and what differentiates us from animals. How does human behavior be quantified? Lemov explains her paper through the workings of Leob and Watson. Leob and Watson's experiments are measured by responses from their subjects. Their experiments have been ground breaking but limited by their scholarships from corporations and policy makers.


Biocapitalism has been created through the new disciplines of biotechnology and bioeconomy. These terms are still relatively confusing to how and when I should apply these sciences since the science is resting in the grey area. Helmreich and past readings go into these categorizations and has left me assured that the scientific world is also confused.


Works cited:


Helmreich, Stefan. Species of Biocapital. Cambridge: Massachusetts Institute of Technology, 2008.


Lemov, Rebecca. World as Laboratory: Experiments with Mice, Mazes, and Men. New York, NY. Hill and Wang.


Images


http://images.google.com/imgres?imgurl=http://farm1.static.flickr.com/190/550057514_bb765ba95c_o.jpg&imgrefurl=http://science.blogdig.net/archives/date/14/June/2007&usg=__uEdgHuESGnAZ2DTEvtXeboWiqEU=&h=310&w=413&sz=37&hl=en&start=7&um=1&tbnid=YNxkiOA5



http://yoursocialburden.dontkeepsearching.com/images/stem-cell.gif



http://images.google.com/imgres?imgurl=http://www.cadth.ca/media/healthupdate/issue9/hta_htupdate_issue-10_e_img_2.jpg&imgrefurl=http://www.cadth.ca/index.php/en/hta/reports-publications/health-technology-update/issue-10-september-2008/assisted-reproductive&usg=__PxyMujtXGDZ3bhS-zDvYGFagdRE=&h=300&w=400&sz=32&hl=en&start=38&um=1&tbnid=OjLWCOWMEVIZ5M:&tbnh=93&tbnw=124&prev=/images%3Fq%3Dreproductive%2Btechnologies%26ndsp%3D21%26hl%3Den%26rlz%3D1C1CHMB_enUS357US357%26sa%3DN%26start%3D21%26um%3D1